Figure 2From: Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer Kaplan-Meier estimates of the probability of survival. Patients with p-mTOR positive showed significantly shorter overall survival (A) and disease-free survival (B) rates than those with p-mTOR negative expression. (p = .011 and p = .006, respectively).Back to article page